The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: FTSE takes cues from Wall Street 'Santa rally'

Wed, 27th Dec 2023 08:26

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

At 0831 GMT, the FTSE 100 was up 0.5% at 7,736.01.

The positive momentum came after the Dow Jones Industrial Average tacked on 159.36 points overnight on its return from Christmas.

Stephen Innes, managing partner at SPI Asset Management, said US equities were "at or above" an overbought state, although that might not have significant implications if economic data did not warrant a rebuttal.

"Especially as the current market juncture coincides with the onset of the 'Santa rally' window, this officially-designated period spans seven sessions, covering the final five sessions of the year and the first two sessions of the new calendar.

"But really, the unofficial Santa Rally window opened in November when Fed Waller dropped the front-end rates anchor.

"Irrespective of the developments this week and early next, 2023 has already witnessed a Santa rally."

Innes noted that the S&P showed a "remarkable" 16% increase from late October lows through Christmas.

"This robust market performance during the specified period underscores the presence of a Santa rally, leaving little room for doubt.

"Aside from the customary Santa seasonality, any gains witnessed for the remainder of this week may be attributed to the notable increase in the probability of a soft landing, as indicated by the latest round of high-impact macroeconomic data from the United States."

Boxing day footfall shows some improvement, China industrial profits rise

In a very quiet day for economic news, fresh retail data showed Boxing Day foot traffic saw a slight uptick, with a 1.4% increase in the number of shoppers compared to the last year.

However, when compared to 2019 before the onset of the Covid-19 pandemic and lockdowns, footfall on Boxing Day was still down by about 30%, according to the data from MRI Software, formerly known as Springboard.

Elsewhere, China's industrial profits saw substantial growth in November, marking a double-digit increase of 29.5%, following a 2.7% rise in October.

The surge in profits was underpinned by an overall improvement in manufacturing and a notable upturn in industrial output during the same month.

However, some sectors of the Chinese economy failed to meet expectations due to persistently weak demand.

Despite the positive momentum in November, data from the National Bureau of Statistics (NBS) in Beijing showed that industrial earnings in the first 11 months of 2023 still showed a year-on-year contraction of 4.4%.

This decline, though significant, was still an improvement from the 7.8% drop reported from January to October.

Anglo American up on reports of partial Woodsmith sale

On London's equity markets, Anglo American was among the top risers amid reports that it was preparing to sell a minority stake in Britain's biggest mining project.

According to the Times, the mining giant was looking to share the cost of the $9bn Woodsmith fertiliser mine in North Yorkshire, with chief executive Duncan Wanblad reportedly telling City analysts it was moving "at pace to find a partner".

Elsewhere, AstraZeneca was in the green after it said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

AstraZeneca said it would acquire all of Gracell's shares at $2 per share in cash, plus a non-tradable contingent value right of 30 cents per ordinary share payable upon achievement of a specified regulatory milestone.

The upfront cash portion represented a 62% premium to Gracell's closing market price on 22 December.

HgCapital Trust was also moving higher after it announced a partial sale of IRIS Software Group (IRIS) to LGP, a private equity firm based in Los Angeles.

The terms of the transaction were not disclosed, but the transaction valued its investment in IRIS at £99.8m.

HGT said it would receive a net distribution of £42.1m after reinvesting a portion of its proceeds in the business alongside other institutional clients of Hg investing through Hg Saturn.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,738.71 0.00%

FTSE 250 (MCX) 19,681.20 0.00%

techMARK (TASX) 4,308.32 0.00%

FTSE 100 - Risers

Ocado Group (OCDO) 751.20p 3.61%

Anglo American (AAL) 1,993.40p 3.19%

Rentokil Initial (RTO) 444.20p 2.52%

Intertek Group (ITRK) 4,270.00p 1.96%

Entain (ENT) 998.60p 1.90%

Endeavour Mining (EDV) 1,819.00p 1.85%

Scottish Mortgage Inv Trust (SMT) 800.40p 1.83%

Glencore (GLEN) 474.45p 1.74%

Spirax-Sarco Engineering (SPX) 10,520.00p 1.50%

Ashtead Group (AHT) 5,452.00p 1.45%

FTSE 100 - Fallers

Pearson (PSON) 952.00p -1.20%

Vodafone Group (VOD) 68.57p -0.85%

Smurfit Kappa Group (CDI) (SKG) 3,162.00p -0.75%

BT Group (BT.A) 126.35p -0.75%

Imperial Brands (IMB) 1,808.50p -0.58%

Coca-Cola HBC AG (CDI) (CCH) 2,279.00p -0.44%

Centrica (CNA) 141.30p -0.42%

Next (NXT) 8,182.00p -0.34%

Haleon (HLN) 320.45p -0.33%

Melrose Industries (MRO) 565.40p -0.21%

FTSE 250 - Risers

PureTech Health (PRTC) 192.40p 5.48%

Diversified Energy Company (DEC) 1,130.50p 3.34%

Darktrace (DARK) 362.50p 3.13%

Bellevue Healthcare Trust (Red) (BBH) 153.00p 2.96%

AO World (AO.) 99.95p 2.62%

HGCapital Trust (HGT) 436.50p 2.22%

BBGI Global Infrastructure S.A. NPV (DI) (BBGI) 143.40p 2.14%

Investec (INVP) 543.40p 2.10%

Future (FUTR) 761.00p 2.08%

Bytes Technology Group (BYIT) 617.50p 2.07%

FTSE 250 - Fallers

Carnival (CCL) 1,306.50p -4.39%

SDCL Energy Efficiency Income Trust (SEIT) 63.40p -3.35%

Trustpilot Group (TRST) 145.30p -2.15%

Jupiter Fund Management (JUP) 89.85p -2.07%

Mitchells & Butlers (MAB) 255.00p -1.92%

TI Fluid Systems (TIFS) 150.60p -1.70%

Empiric Student Property (ESP) 93.00p -1.59%

Domino's Pizza Group (DOM) 378.00p -1.56%

Caledonia Investments (CLDN) 3,495.00p -1.55%

Sirius Real Estate Ltd. (SRE) 92.60p -1.49%

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.